Enanta Pharmaceuticals (ENTA) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Enanta Pharmaceuticals (ENTA) over the last 9 years, with Q4 2025 value amounting to -$3.65.
- Enanta Pharmaceuticals' Times Interest Earned rose 6958.19% to -$3.65 in Q4 2025 from the same period last year, while for Dec 2025 it was -$8.3, marking a year-over-year increase of 2883.52%. This contributed to the annual value of -$11.11 for FY2025, which is 10.6% up from last year.
- Per Enanta Pharmaceuticals' latest filing, its Times Interest Earned stood at -$3.65 for Q4 2025, which was up 6958.19% from -$7.7 recorded in Q3 2025.
- Enanta Pharmaceuticals' Times Interest Earned's 5-year high stood at -$3.65 during Q4 2025, with a 5-year trough of -$18.38 in Q2 2023.
- Moreover, its 3-year median value for Times Interest Earned was -$11.57 (2024), whereas its average is -$11.12.
- As far as peak fluctuations go, Enanta Pharmaceuticals' Times Interest Earned crashed by 1835.76% in 2024, and later soared by 6958.19% in 2025.
- Over the past 3 years, Enanta Pharmaceuticals' Times Interest Earned (Quarter) stood at -$10.14 in 2023, then fell by 18.36% to -$12.0 in 2024, then skyrocketed by 69.58% to -$3.65 in 2025.
- Its Times Interest Earned was -$3.65 in Q4 2025, compared to -$7.7 in Q3 2025 and -$11.68 in Q2 2025.